Such biomarkers might include PD-L1, TMB, LDH, tertiary lymphoid structures (TLSs), tumor-associated macrophages (TAMs), tumor-infiltrating lymphocytes (TILs), and extracellular vesicles (EVs). Here, CD274 is linked to neoplasm.